This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
You may need to consent to allow access to your Summary Care Records (SCR). SCR is an NHS system which provides patient’s information, created from GP medicalrecords, for example, information on patient’ repeated medications. Read more about the emergency supply of medication. Fostair 100/6.
Source: Deloitte Combining these types of health data allows pharmaceuticalcompanies to understand a person’s health and genetic profile better, thereby improving the quality of healthcare products and services. Pharma companies deal with enormous amounts of health data. What Is Health Data Management?
A patient access scheme or commercial arrangement associated with the NICE guidance is a way for pharmaceuticalcompanies to lower the acquisition cost to the NHS to improve its cost-effectiveness, so enabling patients to gain access to high-cost medicine treatments. The NHS price for dupilumab excluding VAT is £1,264.89
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2020 
69 
Let's personalize your content